{
    "title": "Cutting-edge asthma and cancer medicines help pharma giant AstraZeneca to a healthy sales rise",
    "url": "https://www.dailymail.co.uk/money/markets/article-8269627/AstraZeneca-boosted-higher-cancer-medicine-sales.html",
    "date": "2020-04-29",
    "keywords": [
        "cent",
        "astrazeneca",
        "covid19",
        "drug",
        "market",
        "coronavirus",
        "cancer",
        "quarter",
        "revenue",
        "growth",
        "cambridge",
        "share",
        "fund",
        "lung",
        "cell",
        "face",
        "glaxosmithkline",
        "gsk",
        "university",
        "day",
        "jump",
        "farxiga",
        "race",
        "business",
        "month",
        "accounting",
        "china",
        "pandemic",
        "research",
        "investment",
        "account",
        "fee",
        "firm",
        "asthma",
        "tagrisso",
        "respectivelyoncology",
        "rise",
        "treatment",
        "imfinzi",
        "monththey",
        "respiratory",
        "markthere",
        "upswing",
        "renal",
        "metabolism",
        "cvrm",
        "antiplatelet",
        "remedy",
        "brilinta",
        "medication",
        "report",
        "article",
        "ability",
        "calquence",
        "lymphomait",
        "popularity",
        "astrazenecas",
        "newer",
        "companys",
        "track",
        "year",
        "lineup",
        "place",
        "salesrevenue",
        "company",
        "line",
        "term",
        "astrazenecam",
        "disruption",
        "percentage",
        "soriot",
        "focus",
        "therapy",
        "area",
        "region",
        "pipeline",
        "prouder",
        "team",
        "continuity",
        "care",
        "contribute",
        "society",
        "expertise",
        "worldwide",
        "today",
        "publication",
        "update",
        "diy",
        "capital",
        "risk",
        "isa",
        "trade",
        "community",
        "model",
        "affiliate",
        "product",
        "money",
        "commission",
        "editorial",
        "independence"
    ],
    "category": [
        "money",
        "markets"
    ]
}